MannKind Analyst Price Targets

Wall Street analyst price targets and consensus rating for MannKind (MNKD).

Price Target Range — 11 Quarters

Analyst Consensus — 11 Analysts

10Buy

1Hold

Consensus RatingOutperform# Analysts11Avg. Consensus PT$9Upside to Avg. PT+159.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 20, 2026	Cantor Fitzgerald	Olivia Brayer Saunders	Maintained	Overweight	$8
Oct 19, 2026	Chardan Capital	Andreas Argyrides	Initiate	Buy	$10
Oct 7, 2026	Truist Securities	Gregory Renza	PT Cut	Buy	$6→$5
Sep 11, 2026	Cantor Fitzgerald	Olivia Brayer Saunders	Maintained	Overweight	$7
Aug 6, 2026	Wells Fargo	Benjamin Burnett	PT Cut	Overweight	$14→$13
Jul 30, 2026	Wells Fargo	Benjamin Burnett	PT Raise	Overweight	$11→$14
May 7, 2026	RBC Capital	Douglas Miehm	PT Raise	Sector Perform	$4→$5
May 7, 2026	Wells Fargo	Benjamin Burnett	PT Raise	Overweight	$8→$10
May 7, 2026	Mizuho	Anthony Petrone	PT Cut	Outperform	$8→$7
May 7, 2026	HC Wainwright & Co.	Brandon Folkes	PT Raise	Buy	$8→$10
Apr 28, 2026	Wells Fargo	Benjamin Burnett	PT Raise	Overweight	$7→$8
Apr 13, 2026	Mizuho	Anthony Petrone	PT Cut	Outperform	$10→$8
Mar 5, 2026	Wedbush	Yun Zhong	PT Cut	Outperform	$10→$8
Feb 27, 2026	RBC Capital	Douglas Miehm	Downgrade	Outperform→Sector Perform	$8→$4
Feb 27, 2026	Wells Fargo	Benjamin Burnett	PT Cut	Overweight	$8→$7
Feb 27, 2026	HC Wainwright & Co.	Brandon Folkes	PT Cut	Buy	$11→$8
Feb 25, 2026	HC Wainwright & Co.	Brandon Folkes	Maintained	Buy	$11
Jan 26, 2026	HC Wainwright & Co.	Brandon Folkes	Maintained	Buy	$11
Nov 24, 2025	Truist Securities	Gregory Renza	Initiate	Buy	$9
Nov 11, 2025	RBC Capital	Douglas Miehm	PT Cut	Outperform	$8→$8

Analyst Ratings News

PRO
Cantor Fitzgerald Reiterates Overweight on MannKind, Maintains $8 Price Target

Cantor Fitzgerald analyst Olivia Brayer Saunders reiterates MannKind (NASDAQ:MNKD) with a Overweight and maintains $8 price target.

Benzinga Newsdesk

This MannKind Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Analysts initiate coverage: RSI Equal-Weight ($22), NWCL Neutral, HDRN Buy.

Avi Kapoor

PRO
Chardan Capital Initiates Coverage On MannKind with Buy Rating, Announces Price Target of $10

Chardan Capital analyst Andreas Argyrides initiates coverage on MannKind (NASDAQ:MNKD) with a Buy rating and announces Price Target of $10.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on MannKind, Lowers Price Target to $5

Truist Securities analyst Gregory Renza maintains MannKind (NASDAQ:MNKD) with a Buy and lowers the price target from $6 to $5.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Reiterates Overweight on MannKind, Maintains $8 Price Target

Cantor Fitzgerald analyst Olivia Brayer Saunders reiterates MannKind (NASDAQ:MNKD) with a Overweight and maintains $8 price target.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Overweight on MannKind, Lowers Price Target to $13

Wells Fargo analyst Benjamin Burnett maintains MannKind (NASDAQ:MNKD) with a Overweight and lowers the price target from $14 to $13.

Benzinga Newsdesk

MannKind Corp

뉴스

파트너 / 기고자

벤징가 글로벌

MannKind Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Cantor Fitzgerald Reiterates Overweight on MannKind, Maintains $8 Price Target

This MannKind Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

PRO
Chardan Capital Initiates Coverage On MannKind with Buy Rating, Announces Price Target of $10

PRO
Truist Securities Maintains Buy on MannKind, Lowers Price Target to $5

PRO
Cantor Fitzgerald Reiterates Overweight on MannKind, Maintains $8 Price Target

PRO
Wells Fargo Maintains Overweight on MannKind, Lowers Price Target to $13

People Also Watch

People Also Watch

MannKind Corp

뉴스

파트너 / 기고자

벤징가 글로벌

MannKind Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROCantor Fitzgerald Reiterates Overweight on MannKind, Maintains $8 Price Target

This MannKind Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

PROChardan Capital Initiates Coverage On MannKind with Buy Rating, Announces Price Target of $10

PROTruist Securities Maintains Buy on MannKind, Lowers Price Target to $5

PROCantor Fitzgerald Reiterates Overweight on MannKind, Maintains $8 Price Target

PROWells Fargo Maintains Overweight on MannKind, Lowers Price Target to $13

People Also Watch

People Also Watch

PRO
Cantor Fitzgerald Reiterates Overweight on MannKind, Maintains $8 Price Target

PRO
Chardan Capital Initiates Coverage On MannKind with Buy Rating, Announces Price Target of $10

PRO
Truist Securities Maintains Buy on MannKind, Lowers Price Target to $5

PRO
Cantor Fitzgerald Reiterates Overweight on MannKind, Maintains $8 Price Target

PRO
Wells Fargo Maintains Overweight on MannKind, Lowers Price Target to $13